These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3911847)

  • 41. Transient central precocious puberty in non-classic 21-hydroxylase deficiency.
    Speiser PW
    J Pediatr Endocrinol Metab; 1995; 8(4):287-9. PubMed ID: 8821907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP; Jones JV; Barnes K; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
    Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sonographic monitoring of LHRH analogue therapy in idiopathic precocious puberty in young girls.
    Hall DA; Crowley WF; Wierman ME; Simeone JF; McCarthy KA
    J Clin Ultrasound; 1986 Jun; 14(5):331-8. PubMed ID: 3088048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gonadotropin releasing hormone analog treatment in children with congenital adrenal hyperplasia complicated by central precocious puberty.
    Güven A; Nurcan Cebeci A; Hancili S
    Hormones (Athens); 2015; 14(2):265-71. PubMed ID: 25553759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Congenital virilizing adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Study of eleven cases (author's transl)].
    Dunand A; Roger M; Chaussain JL; Nocton F; Job JC
    Sem Hop; 1981 Sep 18-25; 57(33-36):1392-7. PubMed ID: 6270798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NIH conference. Therapeutic applications of luteinizing-hormone-releasing hormone and its analogs.
    Cutler GB; Hoffman AR; Swerdloff RS; Santen RJ; Meldrum DR; Comite F
    Ann Intern Med; 1985 May; 102(5):643-57. PubMed ID: 3920942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Central precocious puberty due to hypothalamic hamartoma in a 7-month-old infant girl.
    Rousso IH; Kourti M; Papandreou D; Tragiannidis A; Athanasiadou F
    Eur J Pediatr; 2008 May; 167(5):583-5. PubMed ID: 17541635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Triptorelin (Triptodur) for central precocious puberty.
    Med Lett Drugs Ther; 2018 Jan; 60(1537):7-8. PubMed ID: 29294465
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist.
    Klein KO; Baron J; Barnes KM; Pescovitz OH; Cutler GB
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2387-9. PubMed ID: 9661615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience.
    Kauli R; Pertzelan A; Ben-Zeev Z; Lewin RP; Kaufman H; Schally AM; Schally AV; Laron Z
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):377-87. PubMed ID: 6232020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. For puberty that comes too soon, new treatment highly effective.
    González ER
    JAMA; 1982 Sep; 248(10):1149-51, 1155. PubMed ID: 7050422
    [No Abstract]   [Full Text] [Related]  

  • 53. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty.
    Weise M; Flor A; Barnes KM; Cutler GB; Baron J
    J Clin Endocrinol Metab; 2004 Jan; 89(1):103-7. PubMed ID: 14715835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.
    Laue L; Jones J; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1993 Jan; 76(1):151-5. PubMed ID: 8421081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome.
    Nunez SB; Calis K; Cutler GB; Jones J; Feuillan PP
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5730-3. PubMed ID: 14671160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Congenital adrenal cortex hyperplasia (AGS). Clinical courses following diagnostic and therapeutic omissions].
    Stolecke H; Zimmermann E
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):409-10. PubMed ID: 4751477
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum concentrations of type I and III procollagen propeptides in healthy children and girls with central precocious puberty during treatment with gonadotropin-releasing hormone analog and cyproterone acetate.
    Hertel NT; Stoltenberg M; Juul A; Main KM; Müller J; Nielsen CT; Lorenzen I; Skakkebaek NE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):924-7. PubMed ID: 8473407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Undulating course of precocious puberty].
    Kolmer M; Schulz U; Herkner K; Frisch H; Waldhauser F
    Padiatr Padol; 1991; 26(6):271-4. PubMed ID: 1838804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Precocious Puberty.
    Banerjee S; Bajpai A
    Indian J Pediatr; 2023 Jun; 90(6):582-589. PubMed ID: 37074536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Depot leuprolide acetate for treatment of precocious puberty.
    Parker KL; Lee PA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):689-91. PubMed ID: 2503536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.